BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts

Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features

(2011) Jenny Paupert et al.   CELL CYCLE

Overcoming resistance to tyrosine kinase inhibitors: Lessons learned from cancer cells treated with EGFR antagonists

(2011) Brent N. Rexer et al.   CELL CYCLE

Twenty Years of Unrelated Donor Hematopoietic Cell Transplantation for Adult Recipients Facilitated by the National Marrow Donor Program

(2008) Chatchada Karanes et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Curcumin and cancer: An “old-age” disease with an “age-old” solution

(2008) Preetha Anand et al.   CANCER LETTERS

Distinct Roles for Mammalian Target of Rapamycin Complexes in the Fibroblast Response to Transforming Growth Factor- 

(2008) R. A. Rahimi et al.   CANCER RESEARCH

Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages

(2008) E. A. Papakonstanti et al.   JOURNAL OF CELL SCIENCE

Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-  Pathways in Prostate Cancer

(2008) S. J. Assinder et al.   MOLECULAR PHARMACOLOGY

Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapy

(2008) Giovanni Martinelli et al.   Nature clinical practice. Oncology